96898 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
Methods for promoting wound healing and muscle regeneration with the cell signaling protein nell1
#3002Combination therapy with anti-CD74 and anti-CD20 antibodies provides enhanced toxicity to B-cell diseases
#3003Muteins of αm lipocalin and method of production therefor
#3004Cyclic polypeptides for the treatment of heart failure
#3005Myostatin inhibitor comprising extracellular water-soluble domains of DLK1 as active ingredient
#3006Bioconjugates of synthetic apelin polypeptides
#3007Monoclonal antibody against EL which inhibits enzyme activity of EL
#3008Method for producing protein
#3009Method for inhibiting euPTX3 to treat nasopharyngeal carcinoma by amino acid sequence
#3010Peptides that inhibit the interaction between ASF1 and histones, and use thereof
#3011Expanded bed adsorption methods for isolation of basic milk proteins including lactoferrin
#3012Dock-and-lock (DNL) complexes for therapeutic and diagnostic use
#3013ENGINEERED PEPTIDE (EP)-DIRECTED PROTEIN INTERCELLULAR DELIVERY SYSTEM AND USES THEREOF
#3014NOVEL COMPOSITIONS AND METHODS FOR PREVENTING OR TREATING CANCER METASTASIS
#3015Multiple signaling pathways induced by hexavalent, monospecific and bispecific antibodies for enhanced toxicity to B-cell lymphomas and other diseases
#3016Endoplasmic reticulum localization signals
#3017PREPARATION FOR IMPROVING MEMORY AND LEARNING AND USE THEREOF
#3018Endomucin as an anti-inflammatory agent
#3019POLYMORPHISMS IN THE HUMAN GENE FOR THE MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1 (MRP-1) AND THEIR USE IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONS
#3020Conformational-switching fluorescent protein probe for detection of alpha synuclein oligomers
#3021RAB6KIFL/KIF20A epitope peptide and vaccines containing the same
#3022Treatment of X-linked hypohidrotic ectodermal dysplasia with ectodysplasin A agonist
#3023Method of enhancing efficacy of blood transfusions
#3024NUCLEOTIDE REPEAT EXPANSION-ASSOCIATED POLYPEPTIDES AND USES THEREOF
#3025BIN1 expression as a marker of cancer
#3026Polypeptides binding to human complement C5
#3027Diagnosis and risk stratification by determining the marker CT-proADM
#3028Polynucleotides encoding ZCYTOR17 ligand antibodies
#3029Kidney-specific tumor vaccine directed against kidney tumor antigen G-250
#3030METHOD OF TREATING AN ISCHEMIA-REPERFUSION INJURY-RELATED DISORDER BY ADMINISTERING GPCR LIGANDS
#3031MONOCYTE-DERIVED NUCLEIC ACIDS AND RELATED COMPOSITIONS AND METHODS
#3032Prion disease-specific epitopes and methods of use thereof
#3033Secreted proteins
#3034Mirac proteins
#3035OXIDIZED LDL INHIBITOR
#3036Biosensor for detecting RAF/KSR family kinase dimerization and uses thereof
#3037TUSC2 therapies
#3038Vault compositions for immunization
#3039Treatment of vasculoproliferative conditions with Lrg1 antagonists
#3040ANTICANCER FUSION PROTEIN
#3041Alpha-1 antitrypsin variant, preparation method thereof and use thereof
#3042Nucleic acids encoding peptides for treating wounds, anti-angiogenic compounds and uses thereof
#3043Myonectin (CTRP15), compositions comprising same, and methods of use
#3044Compositions for enhancing the pluripotency of stem cells
#3045Alternative splicing variants of genes associated with prostate cancer risk and survival
#3046Method for producing multipolar cell
#3047Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
#3048Correction of Crb1 mutations
#3049Expression vector comprising a nucleotide sequence encoding a light-activated ion channel protein (VChR1) and implantable device thereof
#3050Therapeutic approach for polyglutamine degeneration
#3051Methods and compositions for diagnosing and treating cancer
#3052Modulators of MYC and methods of using the same
#3053Neutralizing antibodies and methods of use thereof
#3054Mirac proteins
#3055Gene therapy for neurometabolic disorders
#3056BIOLOGICALLY ACTIVE PROTEINS HAVING INCREASED IN VIVO AND/OR IN VITRO STABILITY
#3057Methods for treating pain by administering peptides derived from human basic proline-rich lacrimal protein
#3058Disulphide bond-stabilized functional soluble MHC class II heterodimers
#3059HE4 based therapy for malignant disease
#3060Inhibitors of T-cell activation
#3061Compositions and methods to modulate cell activity
#3062Companion diagnostic for anti-hyaluronan agent therapy and methods of use thereof
#3063Fusion protein comprising circularly permuted form of trail/Apo2L, coding gene and use thereof
#3064Promoter derived from human gene
#3065PEPTIDES IMMUNOREACTIVE WITH AUTOANTIBODIES FROM PATIENTS SUFFERING FROM RHEUMATOID ARTHRITIS
#3066METHOD FOR THE TREATMENT OF PULMONARY DISEASE AND METHOD OF PRODUCING PROTEINS OF USE THEREIN
#3067Chimeric receptors with 4-1BB stimulatory signaling domain
#3068Gigaxonin fusion protein and methods for treating giant axonal neuropathy
#3069Method for producing phosphoserine incorporated proteins by using SepRS mutants and EF-Tu mutants
#3070TARGETED IDURONATE-2-SULFATASE COMPOUNDS
#3071UTILITY OF INSULIN-LIKE 6 (INSL6) FOR THE TREATMENT OF AUTOIMMUNE DISEASES
#3072Transgenic comprising a human protein with a tendency to aggregate fused to a fluorescent protein
#3073Methods and compositions for generating a mouse
#3074Peptide YY analogs
#3075Anti-FH aptamers, method for producing same, and uses thereof
#3076Vectors encoding rod-derived cone viability factor
#3077Class of therapeutic protein based molecules
#3078VEGF antagonist formulations for intravitreal administration
#3079Method for De-Differentiating A Cell
#3080Sensors and assays for ubiquitin or ubiquitin-like proteins
#3081Fragments of p97 and uses thereof
#3082Antibody producing non-human mammals
#3083Methods and Compositions for Treatment of Diabetes and Related Disorders
#3084Glycosylated polypeptide and drug composition containing said polypeptide
#3085Methods and products for increasing frataxin levels and uses thereof
#3086Modulation of midbody derivatives
#3087Stabilized STAT3 decoy oligonucleotides and uses therefore
#3088Anti-C5A binding moieties with high blocking activity
#3089METHODS AND COMPOSITIONS FOR TREATING AND DIAGNOSING DISEASES
#3090Antibody producing non-human mammals
#3091Method of producing heterogeneous protein
#3092Use of Cell-Permeable Peptide Inhibitors of the JNK Signal Transduction Pathway for the Treatment of Dry Eye Syndrome
#3093Mutations of histone proteins associated with proliferative disorders
#3094Compositions and methods for targeting nuclear import shuttles and treating inflammatory disorders
#3095Compositions of active Wnt protein
#3096Mitochondrial proteins constructs and uses thereof
#3097Isolated B7-H4 specific compositions and methods of use thereof
#3098Gene and mutations thereof associated with seizure and movement disorders
#3099Delaying the progression of diabetes
#3100Method for Assessing Myelodysplastic Syndrome or Myeloid Tumor Predisposition, Polypeptide and Antibody Therefor, and Candidate Screening Method for Therapeutic Drug or Prophylactic Drug Therefor
#3101Protein purification by anion exchange chromatography
#3102TARGET-SPECIFIC PROBE COMPRISING FERRITIN PROTEIN AND DETECTION FOR BIOMARKER USING THE SAME
#3103Vaccine
#3104PAT-LM1 epitopes and methods for using same
#3105METHODS OF TREATING PERIODONTAL INFLAMMATION AND PERIODONTAL BONE LOSS
#3106SERUM AMYLOID P-ANTIBODY FUSION PROTEINS
#3107Extended recombinant polypeptides and compositions comprising same
#3108Modified Human Plasma Polypeptide or Fc Scaffolds and Their Uses
#3109METHOD OF PREVENTING DEVELOPMENT OF PSORIATIC LESIONS
#3110REGULATION OF RECEPTOR EXPRESSION THROUGH DELIVERY OF ARTIFICIAL TRANSCRIPTION FACTORS
#3111METHOD FOR REDUCING THE IMMUNE RESPONSE TO A BIOLOGICALLY ACTIVE PROTEIN
#3112Novel Method of Cancer Diagnosis and Prognosis and Prediction of Response to Therapy
#3113ANTIVIRAL PEPTIDES EFFECTIVE AGAINST HEPATITIS C VIRUS
#3114Treatment for exposure to nerve agent
#3115Isolated B7-H4 specific compositions and methods of use thereof
#3116RbAp48 transgenic mice for drug discovery in age-related memory decline
#3117Production of glycoproteins with low N-glycolylneuraminic acid (Neu5Gc) content
#3118TREATMENT OF AMYLOIDOSIS BY COMPOUNDS THAT REGULATE RETROMER STABILIZATION
#3119Human tear lipocalins which bind PCSK9 and methods of use thereof
#3120PTD-SMAD7 therapeutics
#3121Methods and compositions for the treatment of cancer or other diseases
#3122NOVEL USES OF ELAFIN
#3123INCORPORATION OF METHYL LYSINE INTO POLYPEPTIDES
#3124Use of Zscan4 and Zscan4-dependent genes for direct reprogramming of somatic cells
#3125Notch agonists for the treatment of cancer
#3126Apelin fusion proteins and uses thereof
#3127Method for producing factor H from a plasma precipitation fraction
#3128Modification and compositions of human secretoglobin proteins
#3129Wound healing compositions and treatments
#3130Wound healing compositions and treatments
#3131Methods of Use for Recombinant Human Secretoglobins
#3132Inhibitors of mitochondrial fission and methods of use thereof
#3133AFFINITY REAGENTS AND METHODS FOR DETECTION, PURIFICATION, AND PROTEOMIC ANALYSIS OF METHYLATED PROTEINS
#3134Epigenetic biomarker ZNF545 for diagnosing and prognosis of gastric cancer
#3135GSK3 ligands and polynucleotides encoding GSK3 ligands
#3136Prodrug activation in cancer cells using molecular switches
#3137Vectors encoding a paralytic peptide
#3138ANTIGEN-SPECIFIC METHODS OF DIAGNOSING AND/OR TREATING MYOCARDITIS OR INFLAMMATORY CARDIOMYOPATHY
#3139Immunogenic epitopes for immunotherapy
#3140FGF-10 Complexes
#3141Semaphorin 7a Induced Lung Fibrogenesis Occurs in a CD-4-Dependent, Macrophage Dependent Manner
#3142Stabilized Variant MAML Peptides and Uses Thereof
#3143Dual-AAV vector-based systems and methods for delivering oversized genes to mammalian cells
#3144VEGF-specific capture agents, compositions, and methods of using and making
#3145Production of glycoproteins with low N-glycolylneuraminic acid (NEU5GC) content
#3146Antigens derived from citrullinated 14-3-3 and uses thereof in the diagnosis of rheumatoid arthritis
#3147Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
#3148Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
#3149Peptides with viral infection enhancing properties and their use
#3150Human G Protein-Coupled Receptor and Modulators Thereof for the Treatment of Atherosclerosis and Atherosclerotic Disease and for the Treatment of Conditions Related to MCP-1 Expression
#3151Modified polynucleotides for treating protein deficiency
#3152SENSATION-IMPROVING AGENT
#3153Nanoparticle peptide compositions
#3154WHEY PROTEIN MICELLES AGAINST MUSCLE ATROPHY AND SARCOPENIA
#3155ZCYTOR19 POLYNUCLEOTIDES, POLYPEPTIDES, ANTIBODIES AND METHODS OF USE
#3156Heterologous intron within a signal peptide
#3157Method for producing insoluble aggregate of neurodegenerative-disease-related protein
#3158Peptide vaccines for cancers expressing tumor-associated antigens
#3159Inhibition of cancer metastasis
#3160GLYCOPROTEINS HAVING LIPID MOBILISING PROPERTIES AND THERAPEUTIC APPLICATIONS THEREOF
#3161Modulation of the VPS10p-domain receptor family for the treatment of mental and behavioural disorders
#3162Antibodies which bind to signal peptide-containing molecules
#3163Immunologic Constructs and Methods
#3164Fusion protein containing a single-stranded DNA binding protein and methods for expression and purification of the same
#3165Compositions and methods for introduction of macromolecules into cells
#3166TRANSTHYRETIN VARIANTS
#3167Methods of determining efficacy of treatment in a subject having heart failure
#3168VACCIBODIES TARGETED TO CROSS-PRESENTING DENDRITIC CELLS
#3169Antibody-mediated transduction of heat shock proteins into living cells
#3170Genes and polypeptides relating to breast cancers
#3171Protein complex comprising MCM8 and MCM9 proteins and their use
#3172Antagonists of BMP9, BMP10, ALK1 and other ALK1 ligands, and uses thereof
#3173Modified polynucleotides for treating galactosylceramidase protein deficiency
#3174Methods and pharmaceutical compositions for the treatment of cardiomyopathy due to friedreich ataxia
#3175Modified binding proteins inhibiting the VEGF-A receptor interaction
#3176STIP1 polypeptides and uses thereof
#3177Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
#3178COMPOSITIONS AND METHODS FOR TREATING PAIN
#3179RRECOMBINANT HUMAN SAPOSIN B PROTEIN CONTAINING PHOSPHORYLATED GLUCOSE RING AND USE THEREOF
#3180Targeted delivery of proteins across the blood-brain barrier
#3181Haptens of paliperidone
#3182Haptens of olanzapine
#3183Compositions and Biomarkers for Heart Disease, Injury and Failure and Methods of Use
#3184Methods for treatment of cancer by targeting Sirt5
#3185Fibrosuppressant Biotherapeutics
#3186Biglycan variant polypeptides and methods of use
#3187T cell receptor and uses thereof
#3188Nuclear targeting sequences
#3189SIGNAL-SENSOR POLYNUCLEOTIDES
#3190IL4/IL13 binding repeat proteins and uses
#3191Prion protein ligands and methods of use
#3192Plasminogen and plasmin variants
#3193Drug monitoring methods using the promyelocytic leukemia protein as a redox sensor
#3194Modified polynucleotides for the production of proteins associated with blood and lymphatic disorders
#3195Cell-permeable peptide inhibitors of the JNK signal transduction pathway
#3196METHOD FOR PRODUCING PROTEINS IN PICHIA PASTORIS THAT LACK DETECTABLE CROSS BINDING ACTIVITY TO ANTIBODIES AGAINST HOST CELL ANTIGENS
#3197Modified polynucleotides encoding basic helix-loop-helix family member E41
#3198Aquaporin-4 peptide compositions and methods of use thereof
#3199Brown adipocyte modification
#3200Synthetic peptides and peptide mimetics
#3201Use of endostatin peptides for the treatment of fibrosis
#3202Vault Agents for Treating Chronic Kidney Disease
#3203Methods for treatment of nephrotic syndrome and related conditions
#3204CTRP6 which can be used as therapeutic and prophylactic agent for autoimmune diseases
#3205Screening methods for spinal muscular atrophy
#3206α4β7 peptide dimer antagonists
#3207Methods and compositions for treating and diagnosing diseases
#3208Methods for treatment of stroke or cerebrovascular accidents using an ETreceptor agonist
#3209Mirac proteins
#3210Diagnosis marker, diagnosis method and therapeutic agent for amyotrophic lateral sclerosis, and animal model and cell model developing amyotrophic lateral sclerosis
#3211MECP2E1 gene
#3212CC2D2A gene mutations associated with Joubert syndrome and diagnostic methods for identifying the same
#3213Modified polynucleotides encoding citeD4
#3214Macromolecule transduction domains and methods for identification and uses thereof
#3215TRIBONECTINS
#3216Treatment of myocardial injury with humanin analogs
#3217Methods and compositions for inhibiting neddylation of proteins
#3218Method for detecting pancreatic cancer
#3219mTOR ligands and polynucleotides encoding mTOR ligands
#3220Method of inhibiting binding or activity of MIF by administering a MIF antagonist
#3221Bi-specific fusion proteins
#3222Methods and compositions for treatment of myotonic dystrophy
#3223METHODS AND COMPOSITIONS FOR TREATING DISEASES TARGETING MABA
#3224Biomolecular electronic device and process of use
#3225Galectin-Immunoglobulin Chimeric Molecules
#3226USE OF A TRUNCATED EIF-5A1 POLYNUCLEOTIDE TO INDUCE APOPTOSIS IN CANCER CELLS
#3227TNF SUPERFAMILY TRIMERIZATION INHIBITORS
#3228High affinity SUMO traps
#3229Mutant sodium channel Nav1.7 and methods related thereto
#3230Amphipathic peptide-lipase conjugate having advanced lipase activity and use thereof
#3231Polymutant tau protein variants and their use for recapitulating human tauopathies
#3232Novel Read-Through Fusion Polynucleotides and Polypeptides and Uses Thereof
#3233Gene coded for a MHC class I molecule, plasmid, expression system protein, multimer, reagent and kit to analyze a T cell frequency
#3234Reagent for diagnosing tumor, pharmaceutical composition, and screening method
#3235Methods of identifying FHL1 mutations associated with novel X-linked muscular myopathies
#3236Modified polynucleotides encoding aryl hydrocarbon receptor nuclear translocator
#3237WDR13 as a novel biomarker useful for treating diabetes and cancer
#3238High affinity bivalent helically constrained peptide against cancer
#3239EGFR and C-Met fibronectin type III domain binding molecules
#3240EGFR and c-Met fibronectin type III domain binding molecules
#3241NOVEL PEPTIDES AND USES THEREOF IN THERAPEUTIC METHODS
#3242Synthetic linear apelin mimetics for the treatment of heart failure
#3243Compositions and methods for making selenocysteine containing polypeptides
#3244Compositions and methods for treating, diagnosing and monitoring disease
#3245Appetite stimulating protein
#3246Nucleic acids, methods and kits for the diagnosis of DYT6 primary torsion dystonia
#3247CETP fragments
#3248Modified polynucleotides for the production of proteins associated with blood and lymphatic disorders
#3249Anticaries compositions and probiotics/prebiotics
#3250Method of treating diabetes by a CTRP12 polypeptide
#3251Dairy cattle breeding for improved milk production traits in cattle
#3252Wnt compositions and therapeutic uses of such compositions
#3253Isolated Mammalian Monocyte Cell Genes; Related Reagents
#3254Isolated Mammalian Monocyte Cell Genes; Related Reagents
#3255Modified polynucleotides encoding SIAH E3 ubiquitin protein ligase 1
#3256Modified polynucleotides encoding septin-4
#3257HLA-A2 tumor associated antigen peptides and compositions
#3258Peptide vaccines for cancers expressing tumor-associated antigens
#3259Polymer nanofiber scaffold for a heparin/fibrin based growth factor delivery system
#3260Mitochondrial targeting and therapeutic use thereof
#3261NOVEL ZINC FINGER-LIKE PEPTIDE COMPOSITIONS AS POTENT AGENTS IN CANCER PREVENTION AND TREATMENT
#3262Methods, compositions, and kits for detecting protein aggregates
#3263Anti-tumor drug, medicament, composition, and use thereof
#3264Type I interferon mimetics as therapeutics for cancer, viral infections, and multiple sclerosis
#3265EphA2 T-cell epitope agonists and uses therefore
#3266Method for acquiring a heat-stable antibody-displayed phage
#3267Methods and compositions for the treatment of cancer or other diseases
#3268INTEGRASE COFACTOR
#3269Methods and compositions for gene inactivation
#3270Signal amplification methods for the imaging of protein synthesis and neurotransmitter transport
#3271Mapping cytosine modifications
#3272Compositions and methods for the transfer of a hexosamine to a modified nucleotide in a nucleic acid
#3273Dimeric binding proteins based on modified ubiquitins
#3274Therapeutic peptides and use thereof against huntington's disease
#3275METHODS FOR MODULATING EMBRYONIC STEM CELL DIFFERENTIATION
#3276IMMUNITY INDUCING AGENT
#3277Modified polynucleotides encoding granulysin
#3278MODIFIED POLYNUCLEOTIDES ENCODING CASPASE 6
#3279Targeting deregulated Wnt signaling in cancer using stabilized alpha-helices of BCL-9
#3280Azoline compound and azole compound library and method for producing same
#3281Fc fusion proteins comprising novel linkers or arrangements
#3282Modified vitamin K-dependent polypeptides
#3283Methods of use of soluble CD24 for therapy of rheumatoid arthritis
#3284Modified polynucleotides encoding apoptosis inducing factor 1
#3285MULTIPROTEIN ASSEMBLIES
#3286Modified polynucleotides encoding hepatitis A virus cellular receptor 2
#3287Modified polynucleotides encoding copper metabolism (MURR1) domain containing 1
#3288Modified polynucleotides encoding aquaporin-5
#3289Peptide for protection of allergic respiratory disorders
#3290Immunoglobulin-binding polypeptide
#3291Polynucleotides encoding extracellular-signal-regulated kinase (ERK) heteropolyligand polypeptides
#3292Interleukin-13 binding proteins
#3293CANCER TARGETS AND USES THEREOF
#3294Mouse for predicting a behavior of drugs in humans
#3295Protein Scaffolds for Antibody Mimics and Other Binding Proteins
#3296SPARC ANGIOGENIC DOMAIN AND METHODS OF USE
#3297Method of purifying proteins
#3298STROMAL ANTIGEN 2 (STAG2) COMPOSITIONS AND METHODS
#3299Modified chaperonin 10
#3300Therapeutic DLL4 binding proteins